Featured publications

• Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients

  Authors: Colmenero J, Rodríguez-Perálvarez M, Salcedo M, Arias-Milla A, Muñoz-Serrano A, Graus J, Nuño J, Gastaca M, Bustamante-Schneider J, Cachero A, Lladó L, Caballero A, Fernández-Yunquera A, Loinaz C, Fernández I, Fondevila C, Navasa M, Iñarrairaegui M, Castells L, Pascual S, Ramírez P, Vinaixa C, González-Dieguez ML, González-Grande R, Hierro L, Nogueras F, Otero A, Álamo JM, Blanco-Fernández G, Fábrega E, García-Pajares F, Montero JL, Tomé S, De la Rosa G, Pons JA.

  Reference: JOURNAL OF HEPATOLOGY 2021; 74(1):148-155.

• Donation after circulatory death liver transplantation: consensus statements from the spanish liver transplantation society

  Authors: Hessheimer AJ, Gastaca M, Miñambres E, Colmenero J, Fondevila C, in representation of the SETH Working Group on DCD.

  Reference: TRANSPLANT INTERNATIONAL 2020; 33(8):902-916.

• Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients

  Authors: Millán O, Ruiz P, Fortuna V, Navasa M, Brunet M.

  Reference: Liver International 2020; 40(4):931-946.

• The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation.

  Authors: Hessheimer AJ, Coll E, Ruíz P, Gastaca M, Rivas JI, Gómez M, Sánchez B, Santoyo J, Ramírez P, Parrilla P, Marín LM, Gómez-Bravo MÁ, García-Valdecasas JC, López-Monclús J, Boscá A, López-Andújar R, Fundora-Suárez J, Villar J, García-Sesma Á, Jiménez C, Rodríguez-Laíz G, Lladó L, Rodríguez JC, Barrera M, Charco R, López-Baena JÁ, Briceño J, Pardo F, Blanco G, Pacheco D, Domínguez-Gil B, Sánchez Turrión V, Fondevila C.

  Reference: JOURNAL OF HEPATOLOGY 2019; 70(5):1034-1035.

• Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation.

  Authors: Hessheimer AJ, Coll E, Torres F, Ruíz P, Gastaca M, Rivas JI, Gómez M, Sánchez B, Santoyo J, Ramírez P, Parrilla P, Marín LM, Gómez-Bravo MÁ, García-Valdecasas JC, López-Monclús J, Boscá A, López-Andújar R, Fundora-Suárez J, Villar J, García-Sesma Á, Jiménez C, Rodríguez-Laíz G, Lladó L, Rodríguez JC, Barrera M, Charco R, López-Baena JÁ, Briceño J, Pardo F, Blanco G, Pacheco D, Domínguez-Gil B, Sánchez Turrión V, Fondevila C.

  Reference: JOURNAL OF HEPATOLOGY 2019; 70(4):658-665.

• Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients

  Authors: Millan, Olga; Ruiz, Pablo; Orts, Lara; Ferre, Paula; Crespo, Gonzalo; Santana, Miguel; Fortuna, Virginia; Quintairos, Luis; Navasa, Miguel; Brunet, Merce.

  Reference: Frontiers in Immunology 2019; 10(873):873-.

• Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.

  Authors: Manzardo C, Londoño MC, Castells L, Testillano M, Luis Montero J, Peñafiel J, Subirana M, Moreno A, Aguilera V, Luisa González-Diéguez M, Calvo-Pulido J, Xiol X, Salcedo M, Cuervas-Mons V, Manuel Sousa J, Suarez F, Serrano T, Ignacio Herrero J, Jiménez M, Fernandez JR, Giménez C, Del Campo S, Esteban-Mur JI, Crespo G, de la Rosa G, Rimola A, Miro JM, FIPSE LT-HIV investigators.

  Reference: AMERICAN JOURNAL OF TRANSPLANTATION 2018; 18(10):2513-2522.

• Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients

  Authors: Londoño M; Souza L; Lozano J; Miquel R; Abraldes J; Llovet L; Quaglia A; Rimola A; Navasa M; Sánchez-Fueyo A.

  Reference: Journal Of Hepatology 2018; 69(3):626-634.

• Heparin but not tissue plasminogen activator improves outcomes in DCD liver transplantation in a porcine model.

  Authors: Hessheimer AJ, Vendrell M, Muñoz J, Ruíz Á, Díaz A, Sigüenza LF, Lanzilotta JR, Delgado Oliver E, Fuster J, Navasa M, García-Valdecasas JC, Taurá P, Fondevila C.

  Reference: LIVER TRANSPLANTATION 2018; 24(5):665-676.

• Pilot study of living donor liver transplantation for patients with HCC exceeding Milan criteria (BCLC extended criteria).

  Authors: Llovet JM, Pavel M, Rimola J, Diaz MA, Colmenero J, Saavedra-Perez D, Fondevila C, Ayuso C, Fuster J, Ginès P, Bruix J, Garcia-Valdecasas JC.

  Reference: LIVER TRANSPLANTATION 2018; 24(3):369-379.